002 — Overland Park, Kansas

002 is a clinical research site located in Overland Park, Kansas, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

002 has participated in 1 clinical trials.

Therapeutic areas: Healthy.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Overland Park

Browse all research sites in Kansas · View every site in Overland Park

• The University of Kansas Cancer Center - Indian Creek
• The University of Kansas Cancer Center - Overland Park
• Midwest Cardiology Associates PA, Menorah Medical Center, Centerpoint Medical Center, Overland Park Regional Medical Center Hospital
• University of Kansas Health System
• The University of Kansas Hospital - Indian Creek Campus
• University of Kansas Medical Center Bariatric and Weight Loss Surgery Clinic
• University of Kansas Cancer Center
• Kansas University Cancer Center Overland Park
• University of Kansas Cancer Center-Overland Park
• The University of Kansas Cancer Center,10710 Nall Avenue
• The University of Kansas Cancer Center Breast Surgery Center - Indian Creek Campus
• Saint Luke's Hospital - South

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 002?

002 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 002 conducted?

002 has 1 clinical trials on record. Their work covers Healthy.

Is 002 accredited by Crixeo Clinical Trials?

002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.